市场调查报告书
商品编码
1433402
全球实验室能力验证市场2023-2030Global Laboratory Proficiency Testing Market 2023-2030 |
全球实验室能力验证市场在预测期间(2023-2030年)预计CAGR为7.4%。市场的成长归因于全球产业对品质保证的需求。品质保证是各行业(尤其是食品和饮料行业)的首要任务,以维持消费者的信任并遵守监管标准。能力验证确保了实验室测试程序的可靠性。 2022 年 4 月,BIPEA 启动了一项新的实验室间测试 (PTS 111),让实验室检测食品中的 SEA 至 SEE 型葡萄球菌肠毒素。它指定了用于初步测试的牛奶基质,评估液态牛奶样本中葡萄球菌肠毒素的检测。
全球实验室能力验证市场按行业类型和技术进行细分。根据行业类型,市场分为临床诊断、微生物学、製药、生物製剂等。此外,根据技术,市场细分为聚合酶链反应、免疫分析、色谱法、光谱法等。临床诊断子类别预计将占据该行业类型细分市场的很大一部分市场份额。这种增长可归因于复杂诊断测试的发展、早期诊断的需求以及对精确可靠测试过程的需求增加。
在行业类型中,微生物学细分市场预计将在全球实验室能力验证市场中占据相当大的份额。该细分市场的成长归因于微生物学技术的不断进步。微生物测试方法和技术能够更准确、更全面地识别化妆品配方的微生物污染,推动了能力验证产业的发展。例如,2023年8月,BIPEA推出了最新的能力测试PT 114化妆品微生物挑战测试。该计划的目的是独立评估实验室在化妆品配方中进行微生物挑战测试的能力。
全球实验室能力验证市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于医疗保健意识不断提高以及越来越多的实验室寻求在该地区获得国际认证,预计亚太地区将在全球市场中占据显着份额。
在所有地区中,北美地区预计在预测期内将以相当大的CAGR成长。区域成长归因于对提高测试准确性和置信度的需求不断增长。能力验证计划依赖测试准确性,这对于准确诊断 COVID-19 至关重要。为了提高整体准确性,该程序允许实验室分析整个操作过程,包括样品处理和测试程序。例如,2020 年 4 月,美国病理学家学会 (CAP) 发布了一项新的能力验证 (PT) 计划,用于检测严重急性呼吸症候群冠状病毒 2 (SARS CoV-2)。微生物学委员会试点了一个用于 SARS CoV-2 检测的创新项目,提供非传染性样本并允许实验室检查整个操作过程。
服务于实验室能力验证市场的主要公司包括 AOAC INTERNATIONAL、Laboratory Corp.、LGC Ltd.、Merck KGaA、Thermo Fisher Scientific Inc 等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2022 年 4 月,Spex CertiPrep、NSI Lab Solutions 和美国药典 (USP) 合作,为全球实验室提供强大的能力验证 (PT) 计画。该计划提高实验室和分析师的绩效意识,支持认证要求,增强品质管理体系,提高行业可靠性,并确保整个产品註册和耐久性的监管机构保证。
Global Laboratory Proficiency Testing Market Size, Share & Trends Analysis Report by Industry Type (Clinical Diagnostics, Microbiology, Pharmaceuticals, Biologics, and Others), and by Technology (Polymerase Chain Reaction, Immunoassays, Chromatography, Spectrometry, and Others), Forecast Period (2023-2030)
The global laboratory proficiency testing market is anticipated to grow at a CAGR of 7.4% during the forecast period (2023-2030). The market's growth is attributed to the demand for quality assurance in the industry across the globe. The quality assurance is prioritized in industries, particularly in food and beverage, to maintain consumer trust and compliance with regulatory standards. The proficiency testing ensures the dependability of laboratory testing procedures. in April 2022,BIPEA is launched a new interlaboratory test (PTS 111) that allowed laboratories to detect Staphylococcal enterotoxins type SEA to SEE in food. It specifies milk matrix for preliminary testing, assessing staphylococcal enterotoxins detection in liquid milk samples.
The global laboratory proficiency testing market is segmented on the industry type, and technology. Based on the industry type, the market is sub-segmented into clinical diagnostics, microbiology, pharmaceuticals, biologics, and others. Furthermore, on the basis of technology, the market is sub-segmented into polymerase chain reaction, immunoassays, chromatography, spectrometry, and others. The clinical diagnostics subcategory is expected to capture a significant portion of the market share within the industry type segment. The growth can be attributed to the development of sophisticated diagnostic tests the need for early diagnosis, and the increased need for precise and reliable testing processes.
Among the industry type, the microbiology sub-segment is expected to hold a considerable share of the global Laboratory Proficiency Testing market. The segmental growth is attributed to the growing technological advancements in microbiology. The microbiological testing methodologies and technology that enable more accurate and comprehensive identification of microbial contamination of cosmetic formulations boost the proficiency testing industry. For instance, in August 2023, BIPEA launched latest proficiency test, PT 114 the Cosmetic Microbial Challenge test. The purpose of the program is to independently assess a laboratory's the ability to perform a Microbial Challenge test in cosmetic formulations.
The global laboratory proficiency testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising awareness of healthcare and a growing number of laboratories seeking to obtain international credentials in the region.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising demand for enhancing test accuracy and confidence. The proficiency testing programs develop dependence on testing accuracy, that's essential to accurate COVID-19 diagnosis. To improve overall accuracy, the program allows laboratories to analyze the whole operating process, including sample handling and testing procedures. For instance, in April 2020, The College of American Pathologists (CAP), released a new proficiency testing (PT) program for the detection of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). The Microbiology Committee piloted an innovative project for SARS CoV-2 detection, delivering non-infectious samples and allowing laboratories to examine the complete operation.
The major companies serving the laboratory proficiency testing market includes AOAC INTERNATIONAL, Laboratory Corp., LGC Ltd., Merck KGaA, Thermo Fisher Scientific Inc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Spex CertiPrep, NSI Lab Solutions, and the US Pharmacopeia (USP) partnered to provide a robust proficiency testing (PT) program for laboratories across the globe. The program raises laboratory and analyst performance awareness, supports the requirements for accreditation, enhances quality management systems, promotes industry reliability, and ensures regulator assurance across the product registration and durability.